-
PROVIDERS
Register Here
NGS in advanced breast cancer: exploring recent clinical advancements
Learn how NGS is guiding breast cancer management today. Explore the potential utility of complementary solid tumor and liquid biopsy testing in informing treatment decisions, as well as patient management strategies in the post CDK4/6 inhibitor therapy setting. - LIFE SCIENCES
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
- ABOUT US
Increasing PTS using multimodal data
Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.
Related
View more-
12/06/2022UPCOMING WEBINAR:Multimodal data drives biomarker innovation
Speakers: Ryan Fukushima
Watch replay
Chief Operating Officer, Tempus
Scott Patterson, PhD
Vice President of Biomarker Sciences, Gilead Sciences, Inc.
Shahed Iqbal, PhD
Senior Director and Head of Molecular Epidemiology, Biomarker Sciences, Gilead Sciences, Inc. -
08/18/2022UPCOMING WEBINAR:The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting
Speakers: Ezra Cohen, MD, FRCPSC, FASCO
Watch replay
Chief, Division of Hematology-Oncology, UC San Diego Moores Cancer Center
Mary J. Fidler, MD
Medical Oncology Section Chief, Rush Medical Center
Wade T. Iams, MD, MSCI
Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center
Calvin Chao, MD
SVP, Medical Affairs, Tempus
James L. Chen, MD
SVP, Cancer Informatics, Tempus -
06/23/2022UPCOMING WEBINAR:
Personalize mental health with Pharmacogenomics
Speakers: Brian C. Forsythe, D.O.; Dallas Psychiatry & TMS Center, Joseph D. Stanton, PhD - Associate Director, Medical Affairs
Watch replay